We are live on
!
Find out more
IC
Intersect Capital Portfolio holdings
AUM
$331M
1-Year Est. Return
6.79%
This Fund
S&P 500
This Quarter
Est. Return
+2.89%
1 Year Est. Return
-6.79%
3 Year Est. Return
+57.23%
5 Year Est. Return
+88.96%
10 Year Est. Return
–
AUM
$259M
AUM Growth
+$21.3M
(+9%)
Cap. Flow
+$22.5M
Cap. Flow
% of AUM
8.71%
Top 10 Holdings %
Top 10 Hldgs %
43.7%
Holding
181
New
47
Increased
68
Reduced
35
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.94M |
| 2 |
Welltower
WELL
|
+$1.35M |
| 3 |
Enterprise Products Partners
EPD
|
+$1.03M |
| 4 |
Lockheed Martin
LMT
|
+$1.03M |
| 5 |
Healthpeak Properties
DOC
|
+$950K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SOR
Source Capital
SOR
|
+$2.4M |
| 2 |
DuPont de Nemours
DD
|
+$568K |
| 3 |
Amazon
AMZN
|
+$399K |
| 4 |
EFT
Eaton Vance Floating-Rate Income Trust
EFT
|
+$273K |
| 5 |
CELG
Celgene Corp
CELG
|
+$262K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 42.46% |
| 2 | Technology | 15.31% |
| 3 | Healthcare | 8.18% |
| 4 | Communication Services | 6.96% |
| 5 | Financials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SONN
176
DELISTED
Sonnet BioTherapeutics
SONN
| – | – |
0
| – | -$21K |
|
|
SOR
177
Source Capital
SOR
$383M
| – | – |
-2,400,000
| Closed | -$2.4M |
|
178
Walmart Inc
WMT
$817B
| – | – |
-6,711
| Closed | -$218K |
|
|
ABMD
179
DELISTED
Abiomed Inc
ABMD
| – | – |
-735
| Closed | -$210K |
|
|
AMRB
180
DELISTED
American River Bankshares
AMRB
| – | – |
-10,059
| Closed | -$131K |
|
|
CELG
181
DELISTED
Celgene Corp
CELG
| – | – |
-2,777
| Closed | -$262K |
|
Similar funds
FPS
BWM
TF
CP
RIM
MWM
PPW
HA
Intersect Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Intersect Capital held 181 positions worth $259M, up 9% from $237M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Intersect Capital deployed $22.5M of net new capital in Q2 2019, opening 47 new positions and adding to 68 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 6,752 shares worth $1.98M.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, down from 44% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was DuPont de Nemours, an estimated $568K trimmed.
- Intersect Capital's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 6,752 shares worth $1.98M.
- Intersect Capital added most to Microsoft in Q2 2019, an estimated $920K increase.
- Intersect Capital's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $568K.
- Intersect Capital fully exited Source Capital in Q2 2019, selling an estimated $2.4M.
- Intersect Capital's ten largest holdings make up 44% of its $259M portfolio in Q2 2019.
- Intersect Capital opened 47 new positions and closed 9 in Q2 2019.
- Intersect Capital's portfolio value rose 9% quarter-over-quarter to $259M.
Based on Intersect Capital's 13F filing for Q2 2019, filed 9 Aug 2019.